Latest News and Press Releases

Results from Rhapsido (remibrutinib) pivotal Phase III RemIND trial, the largest study in chronic inducible urticaria, to be highlighted in late-breaker oral presentationNew Phase IIIb REMIXED...

Agreement offers potential best-in-class targeted protein degrader therapy option for people living with B-cell malignanciesCollaboration adds to Roche’s oncology pipeline and offers potential...

WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace First Quantum Security Service to Launch Within SEALCOIN’s Dedicated...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 5, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio...

Phase III ALIGN study results showed reduced rate of kidney function decline by ~34% with Vanrafia vs placebo, based on supportive eGFR slope analysis1Vanrafia reduced protein in urine by 38.3% vs...

MEDIA RELEASE Muttenz, 4 June 2026 Clariant, a sustainability-focused specialty chemical company, today announced the successful placement of EUR 500 million in unsecured Eurobonds issued by its...

WISeKey and Its Subsidiary WISeSat.Space Corp. Announce Confidential Submission of Amended Draft Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission Canton of Zug,...

gategroup continues its market momentum by acquiring 100% of LSG’s well-established activities in Latvia (Riga) and Estonia (Tallinn) from Aurelius, expanding its Northern European footprint to the...

Burckhardt Compression reports stable revenue, record EBIT and net income, and higher profitability despite a challenging market.

Burckhardt Compression: stabiler Umsatz, Rekord bei EBIT und Gewinn, höhere Profitabilität trotz unsicherem Markt und tieferem Auftragseingang.